by James Rudge, PhD, Technical Director, Neoteryx | 6 min read
A “Letter to the Editor” by Christophe P. Stove et al at Ghent University, Belgium, in the April 2021 issue of Clinical Chemistry and Laboratory Medicine (CCLM), reported on a …
Read Storyby Guest Contributor | 5 min read
A unique course at Ghent University in Belgium educates undergraduate pharmacy students on how to apply microsampling in the field of bioanalysis. This blog from Ghent University faculty Members describes …
Read Storyby James Rudge, PhD, Technical Director, Neoteryx | 5 min read
Simultaneous measurement of multi-antibody responses from dried blood samples. A study article published in the July 2021 issue of Frontiers in Immunology used Mitra samples collected from 54 study volunteers to measure antibody levels (IgA, IgG and IgM) raised from N and S antigens in: pre-pandemic, SARS-CoV-2 convalescence and vaccinated cohorts. The study, entitled “Antibody Mediated Immunity to …
Read StoryLearn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.